drugset / Trial / NCT04738422

Determining Airway pH by Compartmental Exhaled Nitric Oxide Levels During Alkaline Buffer Challenge

NCT04738422

Phase 2 Enrolling by invitation 150 enrolled Indiana University
NaSingle-groupOpen-labelDiagnostic

Summary

Airway pH imbalances cause numerous adverse physiological changes within the airways, including hyperreactivity, cough, bronchoconstriction, ciliopathy, decreased response to bronchodilators, bacterial growth, nitrosative/oxidative stress, neutrophilic/eosinophilic inflammation, and cell death. Airway pH is known to be low (acidic) in chronic and acute pulmonary diseases. The gold standard approach to measuring airway pH is to bronchscopically obtain epithelial cell lining fluid using protected brush sampling. The expense and invasive nature of this approach is a barrier to fully characterizing the role of airway pH in the health and disease. In this study, we will evaluate non-invasive clinical methods that can be done using equipment standard in clinical pulmonary function laboratories for measuring airway pH.

Timeline

Start
2020-09-11
Primary completion
2028-07-15
Completion
2028-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycine Other / unclassified Inhaled